Surface Oncology, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2017 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Surface Oncology, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2017 to Q2 2023.
  • Surface Oncology, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was -$28.2M, a 11.8% decline year-over-year.
  • Surface Oncology, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2023 was -$92.5M, a 46.9% decline year-over-year.
  • Surface Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$63.6M, a 19% increase from 2021.
  • Surface Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$78.5M, a 232% decline from 2020.
  • Surface Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was $59.3M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$92.5M -$28.2M -$2.98M -11.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-02
Q1 2023 -$89.5M -$19.7M -$25.9M -418% Jan 1, 2023 Mar 31, 2023 10-Q 2023-08-02
Q4 2022 -$63.6M -$21.3M +$2.72M +11.3% Oct 1, 2022 Dec 31, 2022 8-K 2023-07-03
Q3 2022 -$66.3M -$23.2M -$3.35M -16.8% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-02
Q2 2022 -$63M -$25.2M -$6.23M -32.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 -$56.7M $6.2M +$21.8M Jan 1, 2022 Mar 31, 2022 10-Q 2023-08-02
Q4 2021 -$78.5M -$24.1M -$91.4M -136% Oct 1, 2021 Dec 31, 2021 8-K 2023-07-03
Q3 2021 $12.9M -$19.9M -$4.12M -26.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $17M -$19M -$4.17M -28.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-02
Q1 2021 $21.2M -$15.6M -$38.1M -169% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-02
Q4 2020 $59.3M $67.3M +$83.3M Oct 1, 2020 Dec 31, 2020 10-K 2021-03-09
Q3 2020 -$24M -$15.8M +$1.1M +6.54% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$25.1M -$14.8M +$2.95M +16.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-04
Q1 2020 -$28M $22.6M +$26.8M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-04
Q4 2019 -$54.8M -$16M -$11.2M -237% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-09
Q3 2019 -$43.6M -$16.9M +$344K +2% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-09
Q2 2019 -$43.9M -$17.8M -$1.91M -12% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-09
Q1 2019 -$42M -$4.2M -$35.4M -113% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-09
Q4 2018 -$6.6M -$4.74M +$11M +70% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 -$17.6M -$17.2M -$2.82M -19.6% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-10
Q2 2018 -$14.8M -$15.9M -$9.28M -141% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-10
Q1 2018 -$5.54M $31.2M +$39.8M Jan 1, 2018 Mar 31, 2018 10-K 2020-03-10
Q4 2017 -$45.4M -$15.8M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 -$14.4M Jul 1, 2017 Sep 30, 2017 10-K 2019-03-07
Q2 2017 -$6.57M Apr 1, 2017 Jun 30, 2017 10-K 2019-03-07
Q1 2017 -$8.63M Jan 1, 2017 Mar 31, 2017 10-K 2019-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.